The study conducted by Tan et al. demonstrates that in glioma, the dual inhibition of IGF-1R and STAT3 sensitizes STAT3-low cells and improves the survival of orthotopic xenograft model mouse and concluded that STAT3-mediated expression features can be used for precise treatment of patients (Tan et al., 2019). The gene discussed is STAT3; the disease is central nervous system cancer.